Why is esr elevated in myocardial infarction

Share This Paper. Topics from this paper. Citation Type. Has PDF. Publication Type. More Filters. View 1 excerpt, cites background. The non-infarct patient with coronary artery disease: can a high risk group be identified? Ann NY Acad Sci. Erikssen, J, Aspects of latent coronary heart disease: a prevalence and methodological validation study of apparently healthy, working, middle-aged men, University Hospital Rikshospitalet Medical Department B, Oslo, Norway, Changes in physical fitness and changes in mortality.

Long term effects of smoking on physical fitness and lung function: a longitudinal study of middle-aged men for seven years. Br Med J. Assessment of physical activity by questionnaire and personal interview with particular reference to fitness and coronary mortality.

Eur J Appl Physiol. Erikssen J , Skrede S. Serum lipids and latent coronary insufficiency. Scand J Clin Lab Invest. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Diabetes Care. Angina pectoris in men. Prognostic significance of selected medical factors. Haematocrit: a predictor of cardiovascular mortality? J Intern Med. Klinisk kemi i praktisk medisin 5th edn. Lund: Studentlitteratur; Fibrinogen as a risk factor for coronary heart disease.

Eur Heart J. Bain BJ. Some influences on the ESR and the fibrinogen level in healthy subjects. Clin Lab Haemat. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Interactive role of infection, inflammation and traditional risk-factors in atheroscleosis and coronary artery disease. J Am Coll Cardiol. Schafer Elinder L , Frostegard J. Ateroskleros inte bara en vellevnadssjukdom. Infeksjoner kan vara en riskfaktor for hjart-karlsjukdom. T-lymphocytes and monocytes in atherogenesis. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men.

Coronary plaque disruption. Conflicts of Interest The authors declare no conflicts of interest. References [ 1 ] Ridker, P. Journals Menu. Contact us. All Rights Reserved. Ridker, P. Liuzzo, G. Morrow, D. Ferreiros, E. Biasucci, L. Pietila, K. Sabatine, M.

Barron, H. Timmer, J. Fatih Ozlu, M. Dimitrijevic, O. Berton, G. Sano, T.